NEW YORK, April 4 /PRNewswire-FirstCall/ -- Instacare Corp., (OTC
Bulletin Board: ISCR) a leading Wi-Fi PDA technology provider to the
lodging industry, the developer of patent-pending technologies for e-health
and EMR applications and the distributor of life-saving prescription drugs
and diagnostics, today provided several meaningful announcements.
Instacare has announced the implementation of a series of Supply Chain
medical products agreements through MedAssets Healthcare Supply Chain, one
of the nation's largest and most prestigious medical contract buying and
group discount organizations, and Invacare Supply Group, a division of the
Invacare Corporation. These buying arrangements position Instacare and its
Medicius and PharmaTech subsidiaries to immediately channel a portfolio of
products into the $12+ billion worldwide ostomy and the $4+ billion chronic
wound care health sectors. Instacare will initially distribute ostomy and
wound care products from five separate companies that collectively comprise
more than 60% of the North American markets' current revenue.
"This is the first in an expected series of related announcements
concerning new distribution, expanded product lines and incremental
customer agreements. These arrangements and the additional impending
contracts are the result of focused resource allocation and targeted
efforts over the past nine months. The doubling of our customer and patient
user base, the expanded new markets and enhanced product lines are the
culmination of our efforts to persuade these large and diverse entities of
the added value derived from our medical technology driven distribution
model," commented Keith Berman, Principal Executive Officer of Instacare.
These new arrangements will also provide the company with expanded
lines of diabetic diagnostic products, medical test kit products and other
market related products that are all part of Instacare's chronic illness
distribution focus. The Company will furnish additional information related
to this arrangement in its 2007 guidance scheduled to be released on or
about April 24, 2007.
The advanced wound care and ostomy markets are serviced by companies
such as Johnson & Johnson Medical, Arlington, Texas; ConvaTec, Skillman,
N.J., a division of Bristol-Myers Squibb Co.; Coloplast, Inc. Marietta, GA;
Cymed Ostomey Co., Berkeley, CA; Hollister Corp., Libertyville, IL; 3M
Health Care, St. Paul, Minn.; Smith & Nephew, Memphis, Tenn.; and Kendall
Healthcare Co., Mansfield, Mass, a division of Tyco International.
"We are unique in our industry. We provide a technology that is
desperately needed by physicians and care givers. Our MD@Hand, which is
furnished to care givers free of charge as a component of our overall
distribution strategy, will allow Instacare to aggressively expand its
national footprint. We are confident that we have adopted a fundamentally
sound business and market strategy," Mr. Berman continued. "And we believe
that it will expand our ability to deliver affordable prescriptions,
diagnostics and wound care products nationwide."
Safe Harbor Statement
This release contains forward-looking statements about our business or
financial condition that reflect our assumptions and beliefs based on
information currently available. We can give no assurance that the
expectations indicated by such forward-looking statements will be realized.
There may be other risks and circumstances that we are unable to predict.
When used in this release, words such as "believes," "expects,"
"forecasts," "intends," "projects," "plans," "anticipates," "estimates" and
similar expressions are intended to identify forward-looking statements,
although there may be certain statements not accompanied by such
expressions.
For further information, please contact: Carla Hintz, The Wells Group,
(480) 391-7400 or visit the company's Web Site: www.instacare.net.

SOURCE Instacare Corp.

NEW YORK, April 4 /PRNewswire-FirstCall/ -- Instacare Corp., (OTC
Bulletin Board: ISCR) a leading Wi-Fi PDA technology provider to the
lodging industry, the developer of patent-pending technologies for e-health
and EMR applications and the distributor of life-saving prescription drugs
and diagnostics, today provided several meaningful announcements.
Instacare has announced the implementation of a series of Supply Chain
medical products agreements through MedAssets Healthcare Supply Chain, one
of the nation's largest and most prestigious medical contract buying and
group discount organizations, and Invacare Supply Group, a division of the
Invacare Corporation. These buying arrangements position Instacare and its
Medicius and PharmaTech subsidiaries to immediately channel a portfolio of
products into the $12+ billion worldwide ostomy and the $4+ billion chronic
wound care health sectors. Instacare will initially distribute ostomy and
wound care products from five separate companies that collectively comprise
more than 60% of the North American markets' current revenue.
"This is the first in an expected series of related announcements
concerning new distribution, expanded product lines and incremental
customer agreements. These arrangements and the additional impending
contracts are the result of focused resource allocation and targeted
efforts over the past nine months. The doubling of our customer and patient
user base, the expanded new markets and enhanced product lines are the
culmination of our efforts to persuade these large and diverse entities of
the added value derived from our medical technology driven distribution
model," commented Keith Berman, Principal Executive Officer of Instacare.
These new arrangements will also provide the company with expanded
lines of diabetic diagnostic products, medical test kit products and other
market related products that are all part of Instacare's chronic illness
distribution focus. The Company will furnish additional information related
to this arrangement in its 2007 guidance scheduled to be released on or
about April 24, 2007.
The advanced wound care and ostomy markets are serviced by companies
such as Johnson & Johnson Medical, Arlington, Texas; ConvaTec, Skillman,
N.J., a division of Bristol-Myers Squibb Co.; Coloplast, Inc. Marietta, GA;
Cymed Ostomey Co., Berkeley, CA; Hollister Corp., Libertyville, IL; 3M
Health Care, St. Paul, Minn.; Smith & Nephew, Memphis, Tenn.; and Kendall
Healthcare Co., Mansfield, Mass, a division of Tyco International.
"We are unique in our industry. We provide a technology that is
desperately needed by physicians and care givers. Our MD@Hand, which is
furnished to care givers free of charge as a component of our overall
distribution strategy, will allow Instacare to aggressively expand its
national footprint. We are confident that we have adopted a fundamentally
sound business and market strategy," Mr. Berman continued. "And we believe
that it will expand our ability to deliver affordable prescriptions,
diagnostics and wound care products nationwide."
Safe Harbor Statement
This release contains forward-looking statements about our business or
financial condition that reflect our assumptions and beliefs based on
information currently available. We can give no assurance that the
expectations indicated by such forward-looking statements will be realized.
There may be other risks and circumstances that we are unable to predict.
When used in this release, words such as "believes," "expects,"
"forecasts," "intends," "projects," "plans," "anticipates," "estimates" and
similar expressions are intended to identify forward-looking statements,
although there may be certain statements not accompanied by such
expressions.
For further information, please contact: Carla Hintz, The Wells Group,
(480) 391-7400 or visit the company's Web Site: www.instacare.net.
SOURCE Instacare Corp.